<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Inverness Medical Innovations</title>
	<atom:link href="http://www.stockbloghub.com/tag/inverness-medical-innovations/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Wed, 23 May 2012 20:22:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(IMA) Inverness Medical Innovations &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/07/13/ima-inverness-medical-innovations-momentum-zacks-rank-buy/9797</link>
		<comments>http://www.stockbloghub.com/2009/07/13/ima-inverness-medical-innovations-momentum-zacks-rank-buy/9797#comments</comments>
		<pubDate>Mon, 13 Jul 2009 13:51:28 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[IMA]]></category>
		<category><![CDATA[Inverness Medical Innovations]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=9797</guid>
		<description><![CDATA[Inverness Medical Innovations (IMA) continues to trend higher in response to the company&#8217;s strong first-quarter results, reported in late April, in which the company swung to a profit from last year. First-Quarter Results Sales were up 19% from last year to $443.9 million. Income was up sharply to $771,000, up from a loss of $4.2 million, producing earnings of 56 cents per share, 3 cents ahead of the consensus. Next-Year Estimate Bullish Analysts are bullish on the company&#8217;s long-term prospects, with the next-year estimate pegged at $2.66 per share, a 16% earnings growth projection. Valuations Based on the current-year estimate of $2.29, this stock has a P/E multiple of 14X, in line with the overall market. The Chart Shares of IMA have been rallying for most of the last 7 ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/07/13/ima-inverness-medical-innovations-momentum-zacks-rank-buy/9797/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(IMA) Inverness Medical Technology Inc. &#8211; Momentum &#8211; Zacks Rank Buy</title>
		<link>http://www.stockbloghub.com/2009/02/24/ima-inverness-medical-technology-inc-momentum-zacks-rank-buy/3601</link>
		<comments>http://www.stockbloghub.com/2009/02/24/ima-inverness-medical-technology-inc-momentum-zacks-rank-buy/3601#comments</comments>
		<pubDate>Tue, 24 Feb 2009 22:05:01 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[IMA]]></category>
		<category><![CDATA[Inverness Medical Innovations]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=3601</guid>
		<description><![CDATA[Inverness Medical Technology Inc. (IMA) just reported excellent fourth-quarter results and its share price continues to head higher along an aggressive trend line. Company Description Inverness Medical Technology, Inc. develops and manufactures consumer and professional medical diagnostic products and a range of vitamin and nutritional supplements worldwide. The company was founded in 2001 and has a market cap of $2.04 billion. Fourth-Quarter Results Inverness reported impressive fourth-quarter on Feb 18 that were ahead of expectations. Revenue was up 59% from last year to $459.3 million, largely due to acquisitions. Net income spike to $16.4 million from a loss of $15.8 million in the same period last year. This produced earnings of 66 cents per share, ahead of estimates by 9 cents. Analyst Estimates Analyst estimates have been a bit mixed ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/02/24/ima-inverness-medical-technology-inc-momentum-zacks-rank-buy/3601/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(IMA) Inverness Medical Innovations &#8211; Revenue Jumped 84.7% in the Third Quarter</title>
		<link>http://www.stockbloghub.com/2009/01/26/inverness-medical-innovations-revenue-jumped-847-in-the-third-quarter/2341</link>
		<comments>http://www.stockbloghub.com/2009/01/26/inverness-medical-innovations-revenue-jumped-847-in-the-third-quarter/2341#comments</comments>
		<pubDate>Mon, 26 Jan 2009 19:49:34 +0000</pubDate>
		<dc:creator>Shawn</dc:creator>
				<category><![CDATA[Scientific & Technical Instruments]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[IMA]]></category>
		<category><![CDATA[Inverness Medical Innovations]]></category>
		<category><![CDATA[VitalStocks]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=2341</guid>
		<description><![CDATA[Inverness Medical Innovations, Inc. (IMA) is finding that the health care sector is the place to be during this global slowdown. The stock is cheap. IMA trades with a PEG of only 0.44. Company Description Inverness Medical Innovations manufactures consumer and professional medical diagnostic products. The company focuses on consumer pregnancy and fertility/ovulation test and rapid point-of-care diagnostics. It also has been researching products in the fields of cardiology, women&#8217;s health and infectious diseases. Inverness has R&#38;D facilities in the US, UK, Germany and Israel and manufactures products in the US, UK, China and Japan. Revenue Jumped 84.7% in the Third Quarter On Oct 29, Inverness Medical reported third quarter results where revenue surged 84.7% to $438.8 million compared to $237.6 million in the third quarter of 2007. The growth ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/01/26/inverness-medical-innovations-revenue-jumped-847-in-the-third-quarter/2341/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

